ASIA unversity:Item 310904400/8477
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90120/105277 (86%)
Visitors : 8144017      Online Users : 1819
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Please use this identifier to cite or link to this item:

    Title: Transglutaminase inhibitor cystamine alleviates the abnormality in liver from NZB/W F1 mice
    Authors: Hsu, TC (Hsu, Tsai-Ching);Huang, CY (Huang, Chih-Yang);Chiang, SY (Chiang, Szu-Yi);Lai, WX (Lai, Wen-Xian);Tsai, CH (Tsai, Chang-Hai);Tzang, BS (Tzang, Bor-Show)
    Contributors: Department of Healthcare Administration
    Date: 2008-01
    Issue Date: 2010-03-26 10:52:37 (UTC+8)
    Publisher: Asia University
    Abstract: Increased hepatic abnormality has been observed in patients with systemic lupus erythematosus (SLE) and contributes to the elevated apoptosis that results in severe disease activity. Since cystamine has been demonstrated to be beneficial for NZB/NV F1 mice, this study investigates the effects of cystamine on various inflammatory and stress-related proteins in liver from NZB/W F I mice. Nephelometric analyses and immunoblots were conducted to detect aspartate aminotransferase (AST), alanine aminotransferase (ALT), C-reactive protein (CRP), p53, p21, Gadd45, heat shock protein 70 (HSP70) and cyclooxygenase-2 (COX-2). AST and ALT were reduced in NZB/W F1 mice that were given cystamine and CRP, p53, p21, Gadd45, HSP70 and COX-2 proteins in the liver were reduced in NZB/W F1 mice that were treated with cystamine. Moreover, cystamine has no obvious effect on BALB/c mice. These findings suggest that cystamine reduces the inflammation in liver of NZB/W F1 mice and provide a clue in treatment of SLE with liver abnormality. (c) 2007 Elsevier B.V. All rights reserved.
    Relation: EUROPEAN JOURNAL OF PHARMACOLOGY 579 (1-3): 382-389
    Appears in Collections:[Department of Healthcare Administration] Journal Article

    Files in This Item:

    File Description SizeFormat
    310904400-8477.doc38KbMicrosoft Word184View/Open

    All items in ASIAIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback